Manitoba will receive the newly approved Pfizer bivalent vaccine by the end of this week, and it will be available to anyone 12 or older. Manitoba will receive the newly approved Pfizer bivalent COVID-19 vaccine, which targets Omicron BA.4 and BA.5 subvariants, by the end of this week, the province said in a news release Thursday. Previously, Manitobans 18 or older were eligible for the Moderna bivalent vaccine, which targets the original strain of COVID-19 and the Omicron variant. Public health officials recommend people wait a minimum of six months afer their last dose before getting the bivalent vaccine. As of Oct. 12, a total of 55,109 doses of bivalent vaccine had been administered in Manitoba, the province said.

Source: CBC News October 14, 2022 12:39 UTC